Trade Summary

1 week ago, Troendle August J., serving as President & CEO at Medpace Holdings, Inc. (MEDP), sold 650 shares at $620.27 per share, for a total transaction value of $403,175.50. Following this transaction, Troendle August J. now holds 539,894 shares of MEDP.

This sale represents a 0.12% decrease in Troendle August J.'s stake in the company.

The trade was executed on Thursday, August 27, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 31, 2026 at 4:11 PM ET, 4 days after the trade was made.

Medpace Holdings, Inc. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.